FDA Inspection
Versiti Indiana, Inc.Versiti Indiana, Inc. – FDA Inspection, Aug 4, 2023
Record Details
This FDA Inspection record concerns Versiti Indiana, Inc., with an inspection on August 4, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d4eb9770-d445-458a-b273-6bfbeee80699
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1214844
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Versiti Indiana, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 11, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Versiti Indiana, Inc.
- FDA Inspection 1264016 - 2025-03-11
- FDA Inspection 1032128 - 2017-11-01
- FDA Inspection 957611 - 2016-02-02
- FDA Inspection 884440 - 2014-06-24
- FDA Inspection 799301 - 2012-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.